Bausch Health Announces 2026 Gastrointestinal Health Scholars Program Feb 11, 2026 08:00AM
Bausch Health completes DURECT acquisition for $63 million Sep 11, 2025 08:35AM
Bausch Health completes $63 million DURECT acquisition Sep 11, 2025 08:35AM
Bausch Health Completes Acquisition of DURECT Corporation, Expanding Late-stage Liver Disease Portfolio Sep 11, 2025 08:35AM
Bausch Health Completes Acquisition of DURECT Corporation, Expanding Late-stage Liver Disease Portfolio Sep 11, 2025 08:35AM
View Older Stories

Aug 26, 2025 08:00AM Bausch Health Announces Extension of DURECT Corporation Tender Offer to September 10, 2025
Aug 7, 2025 08:00AM Bausch Health Announces 2025 Gastrointestinal Health Scholars Program Winners
Jul 29, 2025 07:01AM Bausch Health to acquire DURECT for $63 million upfront
Jul 29, 2025 07:00AM Bausch Health to acquire DURECT for $63 million upfront
Jul 29, 2025 07:00AM Bausch Health to Acquire DURECT Corporation, Strengthening Commitment to Developing Innovative Solutions for Patients with Liver Disease
Jul 29, 2025 07:00AM Bausch Health to Acquire DURECT Corporation, Strengthening Commitment to Developing Innovative Solutions for Patients with Liver Disease
Jul 7, 2025 08:00AM Bausch Health's Gastroenterology Business, Salix Pharmaceuticals, Launches Fresh "I Wish I Knew" Campaign to Educate People About Xifaxan(R) (rifaximin) for Adults at Risk of Overt Hepatic Encephalopa
Apr 2, 2025 08:00AM Patient Voices Highlight the Realities of Living with Irritable Bowel Syndrome During IBS Awareness Month
Feb 10, 2025 08:00AM Bausch Health Announces 2025 Salix Gastrointestinal Health Scholars Program
Jan 17, 2025 09:27AM Bausch Health Co. (BHC) Statement on Selection of XIFAXAN for Inflation Reduction Act's Medicare Negotiation Program
Jan 17, 2025 09:25AM Bausch Health Statement on Selection of XIFAXAN(R) (rifaximin) for Inflation Reduction Act's Medicare Negotiation Program
Dec 5, 2024 08:00AM Bausch Health and Salix in Collaboration with Health Organizations Recognize the Second Annual Opioid-Induced Constipation (OIC) Awareness Day
Nov 18, 2024 08:00AM Bausch Health and Salix to Present at the American Association for the Study of Liver Disease (AASLD) the RED-C Phase 3 Study Design for a New Investigational Product Designed to Address Serious Compl
Oct 27, 2024 12:15PM ACG Presidential Plenary to Highlight Analysis of Xifaxan(R) (rifaximin) Risk Reduction of Overt Hepatic Encephalopathy (OHE) Recurrence
Oct 8, 2024 08:00AM Bausch Health and Salix Survey Highlights Urgent Need for Improved Understanding of Liver Disease Across Healthcare Provider Disciplines as Prevalence of Cirrhosis Rises
Aug 13, 2024 07:00AM Bausch Health Announces 2024 Gastrointestinal Health Scholars Program Winners
Jul 31, 2024 12:00AM Bausch Health Announces Second Quarter 2024 Results
Jul 24, 2024 12:36PM Bausch Health (BHC) halted, news pending, company is rumored to be negotiating chapter 11 bankruptcy filing
Jun 20, 2024 05:31PM Bausch Health (BHC) Files Patent Infringement Lawsuit Against Norwich Pharmaceuticals
Jun 20, 2024 05:28PM Bausch Health Brings Patent Infringement Lawsuit Against Norwich Pharmaceuticals
Jun 20, 2024 12:00AM Bausch Health Brings Patent Infringement Lawsuit Against Norwich Pharmaceuticals
Jun 20, 2024 12:00AM Bausch Health Brings Patent Infringement Lawsuit Against Norwich Pharmaceuticals
Jun 20, 2024 12:00AM Bausch Health Brings Patent Infringement Lawsuit Against Norwich Pharmaceuticals
Jun 20, 2024 12:00AM Bausch Health Brings Patent Infringement Lawsuit Against Norwich Pharmaceuticals
Jun 20, 2024 12:00AM Bausch Health Brings Patent Infringement Lawsuit Against Norwich Pharmaceuticals
Jun 20, 2024 12:00AM Bausch Health Brings Patent Infringement Lawsuit Against Norwich Pharmaceuticals
Jun 20, 2024 12:00AM Bausch Health Brings Patent Infringement Lawsuit Against Norwich Pharmaceuticals
Jun 20, 2024 12:00AM Bausch Health Brings Patent Infringement Lawsuit Against Norwich Pharmaceuticals
Jun 20, 2024 12:00AM Bausch Health Brings Patent Infringement Lawsuit Against Norwich Pharmaceuticals
Jun 20, 2024 12:00AM Bausch Health Brings Patent Infringement Lawsuit Against Norwich Pharmaceuticals
May 17, 2024 08:00AM Salix to Present Late-Breaking Data from Phase 2 Trial of Amiselimod in Active Ulcerative Colitis at Digestive Disease Week 2024
May 14, 2024 04:23PM Bausch Health (BHC) Announces Updates Related to Norwich XIFAXAN Matters
May 14, 2024 04:21PM Bausch Health Announces Updates Related to Norwich XIFAXAN Matters
May 9, 2024 08:00AM Salix Pharmaceuticals announces Bellamy Young as Spokesperson for Xifaxan(R) (rifaximin)
May 2, 2024 07:00AM Bausch Health Announces First Quarter 2024 Results
Apr 11, 2024 04:22PM Bausch Health to Announce First-Quarter 2024 Results on May 2
Apr 11, 2024 01:08PM Court of Appeals for the Federal Circuit Issues Ruling in Norwich Case that Prevents FDA Approval of Norwich’s Abbreviated New Drug Application Until 2029
Apr 11, 2024 01:03PM Court of Appeals for the Federal Circuit Issues Ruling in Norwich Case that Prevents FDA Approval of Norwich’s Abbreviated New Drug Application Until 2029
Apr 11, 2024 08:00AM Acne Vulgaris Treatment PrARAZLO(TM) (Tazarotene Lotion, 0.045%) Now Available to Patients Through British Columbia PharmaCare Public Drug Plan
Apr 5, 2024 06:15PM Bausch Health Announces Patent Lawsuit Against Amneal Pharmaceuticals
Apr 2, 2024 08:00AM Based on a New Survey, More Than Half of Surveyed IBS/CIC Patients Feel Alone in Their Experience but Also Find That Social Media Helps Create a Community and Inspires Healthcare Provider Conversation
Mar 6, 2024 08:04AM Bausch Health (BHC) Announces a Phase 2 Investigator-Initiated Study of RELISTOR
Mar 6, 2024 08:00AM Salix Pharmaceuticals Announces a Phase 2 Investigator-Initiated Study of RELISTOR(R) (methylnaltrexone bromide: MNTX) in Patients with Resectable Head and Neck Squamous Cell Carcinoma
Mar 5, 2024 08:00AM New Survey Finds More Than Half of Past U.S. Colonoscopy Patients Wish They Had Known More Information About Colonoscopies Including Prep Medication Options and How To Prepare for the Procedure
Mar 1, 2024 08:00AM Bausch Health Companies to Present at Cowen Annual Health Care Conference
Feb 22, 2024 07:00AM Bausch Health Announces Fourth-Quarter and Full-Year 2023 Results
Feb 12, 2024 08:00AM Salix Announces 2024 Gastrointestinal Health Scholars Program
Feb 1, 2024 04:14PM Bausch Health (BHC) Announces Board Changes
Feb 1, 2024 04:10PM Bausch Health Announces Board Refreshment
Jan 30, 2024 08:00AM CABTREO(TM) (clindamycin phosphate, adapalene and benzoyl peroxide) Topical Gel for the Treatment of Acne Vulgaris Now Available in the U.S.
View Older Stories